Evidence map›Paper›PMID 20544225›Full record

SynthesisSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2010

A systematic review of orofacial pain in patients receiving cancer therapy.

Joel B Epstein, Catherine Hong, Richard M Logan, Andrei Barasch, Sharon M Gordon, Loree Oberle-Edwards, Lorree Oberlee-Edwards, Deborah McGuire, Joel J Napenas, Linda S Elting and 2 more

Erratum issuedAbstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Treatment-related pain in refractory cancer pain: prevalence, mechanisms, and clinical implications in a tertiary referral cohort.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  5. Article
  6. Chronic Oral Complications of Oral Cancer Therapy.Dental clinics of North America · 2025
    Review
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Quality of life, craniomandibular function, and psychosocial factors related to pain and movement in patients with head and neck cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  12. Review
  13. Facial pain, health-related quality of life and trismus-related symptoms up to 5 years post-radiotherapy for head and neck cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  14. Psychological variables associated with quality of life in patients with head and neck cancer: the role of body image distress.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  15. Head and neck cancer survivors' pain in France: the VICAN study.Journal of cancer survivorship : research and practice · 2022
    Article
  16. Review
  17. Dental Evaluation Prior to Cancer Therapy.Frontiers in oral health · 2022
    Review
  18. Glia and Orofacial Pain: Progress and Future Directions.International journal of molecular sciences · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
    Oberlee-Edwards, Lorree [corrected to Oberle-Edwards, Loree]
5 · Who and what money

Authors and funding

12 authors at 9 institutions in 3 countries.

Joel B EpsteinDepartment Oral Medicine and Diagnostic Sciences, University of Illinois, Chicago, IL 60612, USA. jepstein@uic.edu
Catherine Hong
Richard M Logan
Andrei Barasch
Sharon M Gordon
Loree Oberle-Edwards
Lorree Oberlee-Edwards
Deborah McGuire
Joel J Napenas
Linda S Elting
Fred K L Spijkervet
Michael T Brennan
Carolinas Medical Center · USScripps Health · USThe University of Texas MD Anderson Cancer Center · USUniversity of Adelaide · AUUniversity of Alabama at Birmingham · USUniversity of Baltimore · USUniversity of Groningen · NLUniversity of Illinois Chicago · USUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe present the findings of a structured systematic review of the literature assessing orofacial pain induced by malignant disease and/or its therapy (excluding mucositis). This evaluation of the literature published after the 1989 NIH Development Consensus conference on the oral complications of cancer therapies is an effort to assess the prevalence of pain, quality of life and economic impact, and management strategies for cancer therapy-induced orofacial pain.

methodsA systematic medical literature search was conducted with assistance from a research librarian in MEDLINE/PubMed and EMBASE databases for articles published between January 1, 1990 and December 31, 2008. Each study was independently assessed by two reviewers with expertise in the field of oral oncology.

resultsThirty-nine studies assessed pain in the head and neck region. The measure was commonly embedded in quality of life studies. Most of these studies described pain in head and neck cancer (HNC) patients, which therefore became the focus of the report. Pain is common in patients with HNC and is reported by approximately half of patients prior to cancer therapy, 81% during therapy, 70% at the end of therapy, and by 36% at 6 months after treatment. Pain is experienced beyond the 6-month period by approximately one third of patients and is typically more severe than pre-treatment cancer-induced pain.

conclusionsThis systematic review identified the presence of pain before cancer therapy, likely attributable to the cancer; an increase in pain during therapy and the common persistence of pain following cancer treatment. Continuing research should use validated tools to prospectively assess orofacial pain, its causes and pathophysiology, and its effect on quality of life and economic impact. Clinical trials of pain management in this setting are also warranted.

Indexed as

Quality of LifeFacial PainHead and Neck NeoplasmsHumansNeoplasmsSeverity of Illness IndexTime Factors

Identifiers

PMID20544225
OpenAlexW1994436475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.